219 related articles for article (PubMed ID: 31606077)
1. Purification and enzymatic assay of class I histone deacetylase enzymes.
Adams MK; Banks CAS; Miah S; Killer M; Washburn MP
Methods Enzymol; 2019; 626():23-40. PubMed ID: 31606077
[TBL] [Abstract][Full Text] [Related]
2. A toolbox for class I HDACs reveals isoform specific roles in gene regulation and protein acetylation.
Hess L; Moos V; Lauber AA; Reiter W; Schuster M; Hartl N; Lackner D; Boenke T; Koren A; Guzzardo PM; Gundacker B; Riegler A; Vician P; Miccolo C; Leiter S; Chandrasekharan MB; Vcelkova T; Tanzer A; Jun JQ; Bradner J; Brosch G; Hartl M; Bock C; Bürckstümmer T; Kubicek S; Chiocca S; Bhaskara S; Seiser C
PLoS Genet; 2022 Aug; 18(8):e1010376. PubMed ID: 35994477
[TBL] [Abstract][Full Text] [Related]
3. How to Distinguish Between the Activity of HDAC1-3 and HDAC6 with Western Blot.
Beyer M; Kiweler N; Mahboobi S; Krämer OH
Methods Mol Biol; 2017; 1510():355-364. PubMed ID: 27761834
[TBL] [Abstract][Full Text] [Related]
4. Determination of the class and isoform selectivity of small-molecule histone deacetylase inhibitors.
Khan N; Jeffers M; Kumar S; Hackett C; Boldog F; Khramtsov N; Qian X; Mills E; Berghs SC; Carey N; Finn PW; Collins LS; Tumber A; Ritchie JW; Jensen PB; Lichenstein HS; Sehested M
Biochem J; 2008 Jan; 409(2):581-9. PubMed ID: 17868033
[TBL] [Abstract][Full Text] [Related]
5. Histone deacetylase activity assay.
Peng L; Yuan Z; Seto E
Methods Mol Biol; 2015; 1288():95-108. PubMed ID: 25827877
[TBL] [Abstract][Full Text] [Related]
6. Cell-based multi-substrate assay coupled to UHPLC-ESI-MS/MS for a quick identification of class-specific HDAC inhibitors.
Zwick V; Simões-Pires C; Cuendet M
J Enzyme Inhib Med Chem; 2016; 31(sup1):209-214. PubMed ID: 27149362
[TBL] [Abstract][Full Text] [Related]
7. A Sensitive and Flexible Assay for Determining Histone Deacetylase 1 (HDAC1) Activity.
Wu MY; Wu RC
Methods Mol Biol; 2016; 1436():3-13. PubMed ID: 27246204
[TBL] [Abstract][Full Text] [Related]
8. Overlapping and Divergent Actions of Structurally Distinct Histone Deacetylase Inhibitors in Cardiac Fibroblasts.
Schuetze KB; Stratton MS; Blakeslee WW; Wempe MF; Wagner FF; Holson EB; Kuo YM; Andrews AJ; Gilbert TM; Hooker JM; McKinsey TA
J Pharmacol Exp Ther; 2017 Apr; 361(1):140-150. PubMed ID: 28174211
[TBL] [Abstract][Full Text] [Related]
9. HDAC Inhibitor-Induced Mitotic Arrest Is Mediated by Eg5/KIF11 Acetylation.
Nalawansha DA; Gomes ID; Wambua MK; Pflum MKH
Cell Chem Biol; 2017 Apr; 24(4):481-492.e5. PubMed ID: 28392145
[TBL] [Abstract][Full Text] [Related]
10. Preparation and Biochemical Analysis of Classical Histone Deacetylases.
Villagra A; Sahakian E; Seto E
Methods Enzymol; 2016; 573():161-81. PubMed ID: 27372753
[TBL] [Abstract][Full Text] [Related]
11. Endogenous modulators and pharmacological inhibitors of histone deacetylases in cancer therapy.
Spiegel S; Milstien S; Grant S
Oncogene; 2012 Feb; 31(5):537-51. PubMed ID: 21725353
[TBL] [Abstract][Full Text] [Related]
12. RNA-dependent dynamic histone acetylation regulates MCL1 alternative splicing.
Khan DH; Gonzalez C; Cooper C; Sun JM; Chen HY; Healy S; Xu W; Smith KT; Workman JL; Leygue E; Davie JR
Nucleic Acids Res; 2014 Feb; 42(3):1656-70. PubMed ID: 24234443
[TBL] [Abstract][Full Text] [Related]
13. Inhibition of histone deacetylases.
Huang Y; Shaw PG; Davidson NE
Methods Mol Biol; 2011; 791():297-311. PubMed ID: 21913088
[TBL] [Abstract][Full Text] [Related]
14. Kinetic and structural insights into the binding of histone deacetylase 1 and 2 (HDAC1, 2) inhibitors.
Wagner FF; Weïwer M; Steinbacher S; Schomburg A; Reinemer P; Gale JP; Campbell AJ; Fisher SL; Zhao WN; Reis SA; Hennig KM; Thomas M; Müller P; Jefson MR; Fass DM; Haggarty SJ; Zhang YL; Holson EB
Bioorg Med Chem; 2016 Sep; 24(18):4008-4015. PubMed ID: 27377864
[TBL] [Abstract][Full Text] [Related]
15. Selective Inhibition of HDAC1 and HDAC2 as a Potential Therapeutic Option for B-ALL.
Stubbs MC; Kim W; Bariteau M; Davis T; Vempati S; Minehart J; Witkin M; Qi J; Krivtsov AV; Bradner JE; Kung AL; Armstrong SA
Clin Cancer Res; 2015 May; 21(10):2348-58. PubMed ID: 25688158
[TBL] [Abstract][Full Text] [Related]
16. A Fluorescence-Lifetime-Based Binding Assay for Class IIa Histone Deacetylases.
Meyners C; Mertens M; Wessig P; Meyer-Almes FJ
Chemistry; 2017 Mar; 23(13):3107-3116. PubMed ID: 27922200
[TBL] [Abstract][Full Text] [Related]
17. Differential HDAC1/2 network analysis reveals a role for prefoldin/CCT in HDAC1/2 complex assembly.
Banks CAS; Miah S; Adams MK; Eubanks CG; Thornton JL; Florens L; Washburn MP
Sci Rep; 2018 Sep; 8(1):13712. PubMed ID: 30209338
[TBL] [Abstract][Full Text] [Related]
18. An ELISA method to assess HDAC inhibitor-induced alterations to P. falciparum histone lysine acetylation.
Hesping E; Skinner-Adams TS; Fisher GM; Kurz T; Andrews KT
Int J Parasitol Drugs Drug Resist; 2020 Dec; 14():249-256. PubMed ID: 33279862
[TBL] [Abstract][Full Text] [Related]
19. G-quadruplex-based fluorometric biosensor for label-free and homogenous detection of protein acetylation-related enzymes activities.
Wang H; Li Y; Zhao K; Chen S; Wang Q; Lin B; Nie Z; Yao S
Biosens Bioelectron; 2017 May; 91():400-407. PubMed ID: 28063389
[TBL] [Abstract][Full Text] [Related]
20. Phenylpyrrole-based HDAC inhibitors: synthesis, molecular modeling and biological studies.
Brindisi M; Cavella C; Brogi S; Nebbioso A; Senger J; Maramai S; Ciotta A; Iside C; Butini S; Lamponi S; Novellino E; Altucci L; Jung M; Campiani G; Gemma S
Future Med Chem; 2016 Sep; 8(13):1573-87. PubMed ID: 27556815
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
